Pancreatic Cancer Patients Discover Weight Measurements Can Be Deceptive Overview Elevated body mass index (BMI) has been associated with an increased risk of pancreatic cancer (PC). However, cancer-associated weight loss occurring years before diagnosis may have led to an underestimation of this association. The extent to which this potential bias has been
Tag: pancreatic cancer
Dreadful Gastric Cancer And Mortality Risk After Diabetes Diagnosis
Dreadful Gastric Cancer And Mortality Risk After Diabetes Diagnosis Overview Evidence indicates a potential link between diabetes and the risk of gastric cancer, but the conclusions are not definitive, especially with limited research focusing on Asian populations. This study aimed to evaluate the impact of diabetes and its duration on the overall
Blood Culture Tests Reveal Fistula Infection In Febrile Patients
Blood Culture Tests Reveal Fistula Infection In Febrile Patients Overview In this study, the researchers aimed to elucidate the importance of blood culture testing following pancreatoduodectomy (PD), a complex surgical procedure. The investigation focused on the rates of blood culture sampling and positivity during febrile episodes (FEs) in PD patients spanning from
Pancreatic Cancer Danger In Diabetic Women
Pancreatic Cancer Danger In Diabetic Women Overview The study aimed to address the challenge of distinguishing pancreatic cancer-related diabetes from type 2 diabetes, particularly in women with new-onset diabetes. Leveraging retrospective cohort data from Australian women, the researchers developed and validated a predictive model to identify individuals at risk of pancreatic cancer
Survival trends: pancreatic cancer in the USA
survival trends: pancreatic cancer in the USA STUDY BACKGROUND Pancreatic cancer (PC) is a devastating malignancy with a 5-year survival rate of 10%. Despite accounting for only 3% of all new cancer diagnoses, it is the third leading cause of cancer-related deaths in the US. Surgical resection is the only potentially curative
Osteopenia predicts outcomes in pancreatic cancer
Osteopenia predicts outcomes in pancreatic cancer Study Background Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer deaths in the United States and is projected to become the second by 2030. The unfavorable prognosis of PDAC can be attributed to late diagnosis, poor metabolic status, and the resistance of cancer
Pseudouveitis with pancreatic carcinoma: a case study
Pseudouveitis with pancreatic carcinoma: a case study Overview of the Study This study is a report of a case of a 61- year- old man who presented with progressive deterioration of general condition with unilateral recurrent episodes of pseudouveitis presenting as non- granulomatous panuveitis of the left eye related to a choroidal
Genetic Mutations for Predicting Pancreatic Ductal Adenocarcinoma Susceptibility
Genetic Mutations for Predicting Pancreatic Ductal Adenocarcinoma Susceptibility Pancreatic ductal adenocarcinoma (PDAC) is the deadliest malignancy representing about 90% of all pancreatic cancers. PDAC progresses asymptomatically until death and is refractory to most treatment methods. Surgery is the most effective treatment. Nevertheless, it is well known that only 15-20% of PDAC
